VILLA, Federico
VILLA, Federico
Dipartimento di Scienze del Farmaco
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency
2019-01-01 Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C.
Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement)
2021-01-01 Jommi, C.; Armeni, P.; Costa, F.; Alberti, C.; Bandello, F.; Bordonaro, R.; Caprodossi, A.; Di Maio, M.; Gaudioso, A.; Giuliani, G.; Langella, R.; Marata, A. M.; Patarnello, F.; Pinto, C.; Rasi, G.; Villa, F.
Establishing the value of new drugs in Italy
2020-01-01 Villa, F.; Jommi, C.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.
The determinants of market access for medicines: theoretical issues and empirical evidence
2021-01-01 Villa, Federico
Variables affecting pricing of orphan drugs: the Italian case
2021-01-01 Jommi, Claudio; Listorti, Elisabetta; Villa, Federico; Ghislandi, Simone; Genazzani, Armando; Cangini, Agnese; Trotta, Francesco
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency | 1-gen-2019 | Villa, F.; Tutone, M.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G.; Jommi, C. | |
Early access programs and managed entry agreements for medicines in Italy: Results of a Focus Group (Early Access Programs and Managed Entry Agreement) | 1-gen-2021 | Jommi, C.; Armeni, P.; Costa, F.; Alberti, C.; Bandello, F.; Bordonaro, R.; Caprodossi, A.; Di Maio, M.; Gaudioso, A.; Giuliani, G.; Langella, R.; Marata, A. M.; Patarnello, F.; Pinto, C.; Rasi, G.; Villa, F. | |
Establishing the value of new drugs in Italy | 1-gen-2020 | Villa, F.; Jommi, C.; Altamura, G.; Antignani, S.; Cangini, A.; Fortino, I.; Melazzini, M.; Trotta, F.; Tafuri, G. | |
The determinants of market access for medicines: theoretical issues and empirical evidence | 1-gen-2021 | Villa, Federico | |
Variables affecting pricing of orphan drugs: the Italian case | 1-gen-2021 | Jommi, Claudio; Listorti, Elisabetta; Villa, Federico; Ghislandi, Simone; Genazzani, Armando; Cangini, Agnese; Trotta, Francesco |